February 5, 2014

GSK’s China drug sales continue falling in bribery scandal fallout

GlaxoSmithKline’s drug sales continued falling in China amid the fallout from a bribery scandal in that country, but global sales made up for the Chinese setback and contributed to GSK’s overall sales growth in the fourth quarter.

Related content